----
Current ValuationThe current P/E ratio is 27.45, within the reasonable range, cheaper than 58.57% of the time in the past 3 years, and the industry ranks 24/53, the industry Median 6.67.
27.45xP/E
HK$34.80Stock price
HK$1.27Earnings per share
27.45xP/E
Stock priceHK$34.80Earnings per shareHK$1.27
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 28.71x
- Typical range
- 22.95x–40.24x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.67x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.67x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
03692HKHANSOH PHARMA | 27.45x | 23.29% | HK$211.03B |
03933HKUNITED LAB | 25.25x | 55.30% | HK$15.67B |
00460HKSIHUAN PHARM | 20.99x | 322.94% | HK$7.29B |
09989HKHEPALINK | 26.91x | 48.79% | HK$5.95B |
03737HKZHONGZHIPHARM | 28.30x | -- | HK$574.29M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
